🇺🇸 FDA
Patent

US 9724262

Methods of diagnosing and treating neonatal reversion to fetal consciousness

granted A61KA61K31/473A61K31/56

Quick answer

US patent 9724262 (Methods of diagnosing and treating neonatal reversion to fetal consciousness) held by The Regents of the University of California expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/473, A61K31/56, A61K31/565